CEO Sandra Hernandez Appointed to the Institute of Medicine’s Committee to Implement a Pandemic Flu Drug Program

Sandra R. Hernández, MD, has been appointed to the Institute of Medicine’s (IOM) committee on the Prophylactic Use of Antiviral Medications during an Influenza Pandemic. The committee members bring expertise in medicine, public health, public policy, epidemiology, emergency preparedness, and ethics. Their charge is to develop strategies of prophylactic treatment, best practices, and policies for implementing a pandemic influenza antiviral drug program. The committee will examine these issues from October 2007 to March 2008. Their studies will culminate in a workshop of State and local pandemic influenza planners, as well as national and relevant international influenza experts slated for December 2008.

Institute of Medicine's Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic

Dr. June E. Osborn (Chair)
Josiah Macy Foundation

Dr. Karen G. Gervais
Minnesota Center for Health Care Ethics

Dr. Sandra R. Hernández
The San Francisco Foundation

Mr. James G. Hodge
Johns Hopkins Bloomberg School of Public Health

Dr. Nicole Lurie
The RAND Corporation

Dr. Andrew T. Pavia
University of Utah School of Medicine

Dr. M. Patricia Quinlisk
Iowa Department of Public Health

Ms. Eileen Scanlon
Nassau County Department of Health